Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Alzheimer Disease × birtamimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Paraproteinemias 1 Immunoglobulin Light-chain Amyloidosis 1 Amyloidosis 1 Alzheimer Disease 1

Interventions

Dexamethasone 2 ixazomib 1 birtamimab 1 Standard of Care 1 Rosiglitazone 1 Neurofeedback 1 Methotrexate 1 Melphalan 1 Mass Screening 1 Magnetic Resonance Imaging 1 Lysine Acetyltransferase 5 1 Hormones 1 Exercise 1 Cyclophosphamide 1 Control Groups 1 Calcium Dobesilate 1 Bortezomib 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02632786 2019-04-05

PRONTO

Prothena Biosciences Ltd.

Phase 2 Completed

129 enrolled 18 charts

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis, Paraproteinemias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡